Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity.

PMID: 22796336
Revista: MOLECULAR AND CELLULAR ENDOCRINOLOGY
Any: 2012
Referència: Mol Cell Endocrinol. 2012 Nov 5;363(1-2):10-9. doi: 10.1016/j.mce.2012.07.001. Epub 2012 Jul 14.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Escobar-Morreale, Hector F; Insenser, Maria; Lecube, Albert; Montes-Nieto, Rafael; Simo, Rafael; Vendrell, Joan; Vilarrasa, Nuria et al.
DOI: 10.1016/j.mce.2012.07.001

A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.

PMID: 22155090
Revista: TOXICOLOGY AND APPLIED PHARMACOLOGY
Any: 2012
Referència: Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275-87. doi: 10.1016/j.taap.2011.11.007. Epub 2011 Dec 3.
Factor d'impacte: 4.447
Tipus de publicació: Article en revista internacional
Autors: , , , et al.
DOI: 10.1016/j.taap.2011.11.007

A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.

PMID: 22155090
Revista: TOXICOLOGY AND APPLIED PHARMACOLOGY
Any: 2012
Referència: Toxicol Appl Pharmacol. 2012 Jan 15;258(2):275-87. doi: 10.1016/j.taap.2011.11.007. Epub 2011 Dec 3.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; et al.
DOI: 10.1016/j.taap.2011.11.007

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

PMID: 20820909
Revista: INVESTIGATIONAL NEW DRUGS
Any: 2012
Referència: Invest New Drugs. 2012 Feb;30(1):299-305. doi: 10.1007/s10637-010-9529-9. Epub 2010 Sep 7.
Factor d'impacte: 3.072
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , , et al.
DOI: 10.1007/s10637-010-9529-9

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

PMID: 20820909
Revista: INVESTIGATIONAL NEW DRUGS
Any: 2012
Referència: Invest New Drugs. 2012 Feb;30(1):299-305. doi: 10.1007/s10637-010-9529-9. Epub 2010 Sep 7.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1007/s10637-010-9529-9

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

PMID: 21447616
Revista: ANNALS OF ONCOLOGY
Any: 2012
Referència: Ann Oncol. 2012 Jan;23(1):119-27. Epub 2011 Mar 29.
Factor d'impacte: 6.425
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , , et al.
DOI: 10.1093/annonc/mdr046

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

PMID: 32018352
Revista: ANNALS OF ONCOLOGY
Any: 2012
Referència: Ann Oncol. 2012 Jan;23(1):119-127. doi: 10.1093/annonc/mdr046. Epub 2019 Dec 4.
Factor d'impacte: 6.425
Tipus de publicació: Article en revista internacional
Autors: Countouriotis, A M, Ruiz-Garcia, A, Wei, G, Tursi, J M, Guillen-Ponce, C, Carrato, A, Aranda, E, Saunders, M P, Iveson, T J, Ramos, F J et al.
DOI: 10.1093/annonc/mdr046

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

PMID: 21447616
Revista: ANNALS OF ONCOLOGY
Any: 2012
Referència: Ann Oncol. 2012 Jan;23(1):119-27. Epub 2011 Mar 29.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1093/annonc/mdr046

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

PMID: 32018352
Revista: ANNALS OF ONCOLOGY
Any: 2012
Referència: Ann Oncol. 2012 Jan;23(1):119-127. doi: 10.1093/annonc/mdr046. Epub 2019 Dec 4.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Aranda, E; Carrato, A; Chau, I; Countouriotis, A M; Cunningham, D; Guillen-Ponce, C; Iveson, T J; Ramos, F J; Ruiz-Garcia, A; Saunders, M P et al.
DOI: 10.1093/annonc/mdr046

A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non-Small-Cell Lung Cancer.

PMID: 22609229
Revista: Clinical Lung Cancer
Any: 2012
Referència: Clin Lung Cancer. 2012 Nov;13(6):432-41. doi: 10.1016/j.cllc.2012.03.004. Epub 2012 May 19.
Factor d'impacte: 2.944
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , et al.
DOI: 10.1016/j.cllc.2012.03.004

A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non-Small-Cell Lung Cancer.

PMID: 22609229
Revista: Clinical Lung Cancer
Any: 2012
Referència: Clin Lung Cancer. 2012 Nov;13(6):432-41. doi: 10.1016/j.cllc.2012.03.004. Epub 2012 May 19.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; ; ; et al.
DOI: 10.1016/j.cllc.2012.03.004

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

PMID: 22006123
Revista: CANCER
Any: 2012
Referència: Cancer. 2012 Jun 15;118(12):3128-34. doi: 10.1002/cncr.26510. Epub 2011 Oct 17.
Factor d'impacte: 4.771
Tipus de publicació: Article en revista internacional
Autors: , , , , , , et al.
DOI: 10.1002/cncr.26510

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

PMID: 22006123
Revista: CANCER
Any: 2012
Referència: Cancer. 2012 Jun 15;118(12):3128-34. doi: 10.1002/cncr.26510. Epub 2011 Oct 17.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: ; ; ; ; ; ; et al.
DOI: 10.1002/cncr.26510

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.

PMID: 23280790
Revista: ANNALS OF NEUROLOGY
Any: 2012
Referència: Ann Neurol. 2012 Nov;72(5):716-29. doi: 10.1002/ana.23664.
Factor d'impacte: 11.089
Tipus de publicació: Article en revista internacional
Autors: Mendioroz, Maite, del Rio-Espinola, Alberto, Fernandez-Cadenas, Israel, Giralt, Dolors, Quiroga, Adoracion, Gutierrez-Agullo, Maria, Quintana, Manuel, Fernandez-Alvarez, Patricia, Domingues-Montanari, Sophie, Canovas, D et al.
DOI: 10.1002/ana.23664

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.

PMID: 23280790
Revista: ANNALS OF NEUROLOGY
Any: 2012
Referència: Ann Neurol. 2012 Nov;72(5):716-29. doi: 10.1002/ana.23664.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alvarez-Sabin, J; Arboix, A; Arenillas, J F; Aymerich, N; Canovas, D; Castellanos, Mar; Chacon, Pilar; Cocho, D; Cuadrado-Godia, Elisa; de Vilanova, Arnau et al.
DOI: 10.1002/ana.23664

A predictive scoring instrument for tuberculosis lost to follow-up outcome.

PMID: 22938040
Revista: RESPIRATORY RESEARCH
Any: 2012
Referència: Respir Res. 2012 Sep 2;13:75. doi: 10.1186/1465-9921-13-75.
Factor d'impacte: 3.36
Tipus de publicació: Article en revista internacional
Autors: Vidal, Rafael, Rodrigo, Teresa, Cayla, Joan A, Casals, Marti, Garcia-Garcia, Jose M, Caminero, Jose A, Ruiz-Manzano, Juan, Blanquer, Rafael, Valencia, E, Vargas, A et al.
DOI: 10.1186/1465-9921-13-75

A predictive scoring instrument for tuberculosis lost to follow-up outcome.

PMID: 22938040
Revista: RESPIRATORY RESEARCH
Any: 2012
Referència: Respir Res. 2012 Sep 2;13:75. doi: 10.1186/1465-9921-13-75.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Altet, Neus; Alvarez, F; Anibarro, L; Barron, M; Blanquer, Rafael; Bustamante, A; Calpe, Jose L; Caminero, Jose A; Canas, F; Casals, Marti et al.
DOI: 10.1186/1465-9921-13-75

A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.

PMID: 21905008
Revista: ARTHRITIS AND RHEUMATISM
Any: 2012
Referència: Arthritis Rheum. 2012 Jan;64(1):264-71. doi: 10.1002/art.33325.
Factor d'impacte: 7.866
Tipus de publicació: Article en revista internacional
Autors: Camps, Mayte, Vonk, M C, Knaapen, H, Beretta, L, Rueda, B, Hesselstrand, R, Herrick, A, Worthington, J, Hunzelman, N, Denton, C P et al.
DOI: 10.1002/art.33325

A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.

PMID: 21905008
Revista: ARTHRITIS AND RHEUMATISM
Any: 2012
Referència: Arthritis Rheum. 2012 Jan;64(1):264-71. doi: 10.1002/art.33325.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Aguirre, M angeles; Airo, P; Beretta, L; Bossini-Castillo, L; Broen, J C A; Callejas Rubio, Jose Luis; Camps, Mayte; Carreira, Patricia; Castellvi, Ivan; Coenen, M J H et al.
DOI: 10.1002/art.33325

A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample.

PMID: 22908361
Revista: CEPHALALGIA
Any: 2012
Referència: Cephalalgia. 2012 Oct;32(14):1076-80. doi: 10.1177/0333102412457090. Epub 2012 Aug 20.
Factor d'impacte: 3.43
Tipus de publicació: Article en revista internacional
Autors: Sintas, Celia, Carreno, Oriel, Fernandez-Morales, Jessica, Cacheiro, Pilar, Sobrido, Maria-Jesus, Narberhaus, Bernat, Pozo-Rosich, Patricia, Macaya, Alfons, Cormand, Bru et al.
DOI: 10.1177/0333102412457090

A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample.

PMID: 22908361
Revista: CEPHALALGIA
Any: 2012
Referència: Cephalalgia. 2012 Oct;32(14):1076-80. doi: 10.1177/0333102412457090. Epub 2012 Aug 20.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Cacheiro, Pilar; Carreno, Oriel; Cormand, Bru; Fernandez-Morales, Jessica; Macaya, Alfons; Narberhaus, Bernat; Pozo-Rosich, Patricia; Sintas, Celia; Sobrido, Maria-Jesus et al.
DOI: 10.1177/0333102412457090

A review of opioid prescription in a teaching hospital in Colombia.

PMID: 23049273
Revista: Journal of pain research
Any: 2012
Referència: J Pain Res. 2012;5:237-42. doi: 10.2147/JPR.S32603. Epub 2012 Jul 30.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: Moyano, Jairo, Figueras, Albert et al.
DOI: 10.2147/JPR.S32603

A review of opioid prescription in a teaching hospital in Colombia.

PMID: 23049273
Revista: Journal of pain research
Any: 2012
Referència: J Pain Res. 2012;5:237-42. doi: 10.2147/JPR.S32603. Epub 2012 Jul 30.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: Figueras, Albert; Moyano, Jairo et al.
DOI: 10.2147/JPR.S32603

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.

PMID: 21717435
Revista: CANCER
Any: 2012
Referència: Cancer. 2012 Jan 15;118(2):410-7. doi: 10.1002/cncr.26273. Epub 2011 Jun 29.
Factor d'impacte: 4.771
Tipus de publicació: Article en revista internacional
Autors: , , , , , , , , Bueno Aribayos, Javier, et al.
DOI: 10.1002/cncr.26273

Publicacions

Cercador de Publicacions

A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity.

A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.

A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells.

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors.

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non-Small-Cell Lung Cancer.

A Phase Ib, Dose-Finding Study of Erlotinib in Combination With a Fixed Dose of Pertuzumab in Patients With Advanced Non-Small-Cell Lung Cancer.

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.

A predictive scoring instrument for tuberculosis lost to follow-up outcome.

A predictive scoring instrument for tuberculosis lost to follow-up outcome.

A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.

A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.

A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample.

A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample.

A review of opioid prescription in a teaching hospital in Colombia.

A review of opioid prescription in a teaching hospital in Colombia.

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.

Patronat:

Col·labora:

Acreditacions: